Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Caribou Biosciences (CRBU) Return on Capital Employed (2021 - 2025)

Caribou Biosciences (CRBU) has disclosed Return on Capital Employed for 3 consecutive years, with 0.28% as the latest value for Q4 2023.

  • On a quarterly basis, Return on Capital Employed rose 2.0% to 0.28% in Q4 2023 year-over-year; TTM through Dec 2023 was 0.28%, a 2.0% increase, with the full-year FY2024 number at 0.49%, down 18.0% from a year prior.
  • Return on Capital Employed was 0.28% for Q4 2023 at Caribou Biosciences, up from 0.3% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.16% in Q4 2021 to a low of 0.3% in Q4 2022.
  • A 3-year average of 0.23% and a median of 0.22% in 2021 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: dropped -14bps in 2022, then rose 2bps in 2023.
  • Caribou Biosciences' Return on Capital Employed stood at 0.16% in 2021, then plummeted by -86bps to 0.3% in 2022, then grew by 6bps to 0.28% in 2023.
  • Per Business Quant, the three most recent readings for CRBU's Return on Capital Employed are 0.28% (Q4 2023), 0.3% (Q4 2022), and 0.25% (Q3 2022).